Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Net Income (2018 - 2025)

Historic Net Income for AVITA Medical (RCEL) over the last 8 years, with Q4 2025 value amounting to -$11.6 million.

  • AVITA Medical's Net Income fell 102.78% to -$11.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$48.6 million, marking a year-over-year increase of 2133.57%. This contributed to the annual value of -$48.6 million for FY2025, which is 2133.57% up from last year.
  • Latest data reveals that AVITA Medical reported Net Income of -$11.6 million as of Q4 2025, which was down 102.78% from -$13.2 million recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's Net Income registered a high of -$4.7 million during Q2 2021, and its lowest value of -$18.7 million during Q1 2024.
  • For the 5-year period, AVITA Medical's Net Income averaged around -$10.4 million, with its median value being -$9.9 million (2025).
  • Its Net Income has fluctuated over the past 5 years, first soared by 6346.6% in 2021, then crashed by 19958.09% in 2023.
  • Over the past 5 years, AVITA Medical's Net Income (Quarter) stood at -$5.9 million in 2021, then grew by 7.73% to -$5.5 million in 2022, then plummeted by 199.58% to -$16.4 million in 2023, then soared by 30.17% to -$11.5 million in 2024, then dropped by 1.03% to -$11.6 million in 2025.
  • Its last three reported values are -$11.6 million in Q4 2025, -$13.2 million for Q3 2025, and -$9.9 million during Q2 2025.